{
    "code": "02022207",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022207",
    "time": "2020-02-25 12:51:57",
    "許可證字號": "衛署藥輸字第022207號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/10\/25",
    "註銷理由": "自請註銷",
    "有效日期": "107\/06\/11",
    "發證日期": "87\/06\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202220701",
    "中文品名": "康利斯微脂粒注射劑",
    "英文品名": "CAELYX CONCENTRATE FOR INFUSION",
    "適應症": "CAELYX用於治療CD4數量低下(",
    "劑型": "270注射劑",
    "包裝": "100小瓶以下盒裝 10公撮小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥",
        "申請商名稱": "1507401100  嬌生股份有限公司",
        "申請商地址": "台北市大安區敦化南路二段319號4、5樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FBE0009000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "TURNHOUTSEWEG 30, B-2340, BEERSE, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        },
        {
            "製造廠名稱": "FUS0030300  DSM Pharmaceuticals,Inc.",
            "製造廠廠址": "5900 Martin Luther King Jr. Highway,Greenville,NC27834,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "Sterile filtration process and primary packaging"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "(PEGYLATED LIPOSOMAL",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020222070006.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022207&Seq=007&Type=9"
        }
    ]
}